Search - tctmd.com

Displaying 41 - 60 of 92

Sort: Relevancy | Date

Presentation THT 2023

Applications of Gene Therapy in Cardiomyopathies (TBD)

Presenter: Eric Adler

March 20, 2023

Presentation THT 2023

Re-Poll: Revascularization or Medical Therapy?

Presenter: Dor Lotan

March 20, 2023

Presentation THT 2023

Poll: Revascularization or Medical Therapy?

Presenter: Dor Lotan

March 20, 2023

Presentation THT 2023

Assessing the Residual Risk: What Gaps Should New Technologies Fill?

Presenter: Javed Butler

March 20, 2023

Presentation THT 2023

The AI Revolution and How It Is Impacting Health Care Delivery in Heart Failure

Presenter: Nir Uriel

March 20, 2023

Presentation THT 2023

Recent Advances in the Medical Treatment of Patients With Decompensated Heart Failure

Presenter: Alexandre Mebazaa

March 20, 2023

Presentation THT 2023

Contemporary Implementation of Guideline-Directed Therapy for Heart Failure

Presenter: Gad Cotter

March 20, 2023

Presentation THT 2023

SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits

Presenter: Milton Packer

March 20, 2023

Presentation THT 2023

The Impact of SGLT2 Inhibitors Across the Spectrum of Heart Failure

Presenter: Scott Solomon

March 20, 2023

Presentation THT 2023

Opening Talk: Innovation and Technologies to Enhance the Care of Patients With Heart Failure

Presenter: Daniel Burkhoff

March 20, 2023

Presentation CTO 2023

CTO and Higher Risk PCI in a HBR Patient: What Should I Be Doing With DAPT +/- Anticoagulation Therapy?

Presenter: Roxana Mehran

February 24, 2023

Presentation TCT 2022

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

Presenter: Seung Hun Lee

September 19, 2022

Presentation TCT 2022

TCT 19: Thrombin Generation and Endothelial Progenitor Cell Function in Patients with Acute Myocardial Infarction Treated with Prasugrel versus Ticagrelor

Presenter: Mark Kheifets

September 17, 2022

Presentation THT 2022

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Presenter: Barry Greenberg

February 01, 2022

Session XI: Future Directions and Challenges in the MedTech Field - Featured Technology: Real-World Evidence Generation Technology Using Artificial Intelligence and Deep Learning to Predict Disease Risk and Efficacy of Therapy (HOLMUSK)

Presentation TCT 2019

Featured Technology: Real-World Evidence Generation Technology Using Artificial Intelligence and Deep Learning to Predict Disease Risk and Efficacy of Therapy (HOLMUSK)

Presenter: Joydeep Sarkar

September 26, 2019

Presentation TCT 2018

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Duk-Woo Park

September 23, 2018

Presentation TCT 2017

Shockwave Therapy for Calcified Coronary Lesions: Device, Data, and Case Reviews

Presenter: Salvatore Brugaletta, Philippe Genereux, Jonathan M. Hill

November 01, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

Presentation Fellows 2017

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Manish A. Parikh, David J. Cohen

April 07, 2017

Presentation Fellows 2017

Antiplatelet Therapy for the Interventionalist

Presenter: Manish A. Parikh, Gregg W. Stone

April 07, 2017

Advertisement

Applications of Gene Therapy in Cardiomyopathies (TBD)

Re-Poll: Revascularization or Medical Therapy?

Poll: Revascularization or Medical Therapy?

Assessing the Residual Risk: What Gaps Should New Technologies Fill?

The AI Revolution and How It Is Impacting Health Care Delivery in Heart Failure

Recent Advances in the Medical Treatment of Patients With Decompensated Heart Failure

Contemporary Implementation of Guideline-Directed Therapy for Heart Failure

SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits

The Impact of SGLT2 Inhibitors Across the Spectrum of Heart Failure

Opening Talk: Innovation and Technologies to Enhance the Care of Patients With Heart Failure

CTO and Higher Risk PCI in a HBR Patient: What Should I Be Doing With DAPT +/- Anticoagulation Therapy?

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

TCT 19: Thrombin Generation and Endothelial Progenitor Cell Function in Patients with Acute Myocardial Infarction Treated with Prasugrel versus Ticagrelor

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Featured Technology: Real-World Evidence Generation Technology Using Artificial Intelligence and Deep Learning to Predict Disease Risk and Efficacy of Therapy (HOLMUSK)

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Shockwave Therapy for Calcified Coronary Lesions: Device, Data, and Case Reviews

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antiplatelet Therapy for the Interventionalist

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content